alpha-synuclein has been researched along with Influenza--Human* in 2 studies
1 review(s) available for alpha-synuclein and Influenza--Human
Article | Year |
---|---|
Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease.
The disappointments of a series of large anti-amyloid trials have brought home the point that until the driving force behind Alzheimer's disease, and the way it causes harm, are firmly established and accepted, researchers will remain ill-equipped to find a way to treat patients successfully. The origin of inflammation in neurodegenerative diseases is still an open question. We champion and expand the argument that a shift in intracellular location of α-synuclein, thereby moving a key methylation enzyme from the nucleus, provides global hypomethylation of patients' cerebral DNA that, through being sensed by TLR9, initiates production of the cytokines that drive these cerebral inflammatory states. After providing a background on the relevant inflammatory cytokines, this commentary then discusses many of the known alternatives to the primary amyloid argument of the pathogenesis of Alzheimer's disease, and the treatment approaches they provide. A key point to appreciate is the weight of evidence that inflammatory cytokines, largely through increasing insulin resistance and thereby reducing the strength of the ubiquitously important signaling mediated by insulin, bring together most of these treatments under development for neurodegenerative disease under the one roof. Moreover, the principles involved apply to a wide range of inflammatory diseases on both sides of the blood brain barrier. Topics: alpha-Synuclein; Alzheimer Disease; Animals; Cytokines; DNA Methylation; Epigenesis, Genetic; Humans; Inflammation; Influenza, Human; Insulin Resistance; Lead; Mice; Neurodegenerative Diseases; Parkinson Disease; RNA, Untranslated; Toll-Like Receptor 9 | 2013 |
1 other study(ies) available for alpha-synuclein and Influenza--Human
Article | Year |
---|---|
Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation.
Neurodegenerative diseases feature specific misfolded or misassembled proteins associated with neurotoxicity. The precise mechanisms by which protein aggregates first arise in the majority of sporadic cases have remained unclear. Likely, a first critical mass of misfolded proteins starts a vicious cycle of a prion-like expansion. We hypothesize that viruses, having evolved to hijack the host cellular machinery for catalyzing their replication, lead to profound disturbances of cellular proteostasis, resulting in such a critical mass of protein aggregates. Here, we investigated the effect of influenza virus (H1N1) strains on proteostasis of proteins associated with neurodegenerative diseases in Lund human mesencephalic dopaminergic cells in vitro and infection of Topics: alpha-Synuclein; Animals; Dopaminergic Neurons; Female; Homeodomain Proteins; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mice; Mice, Knockout; Nerve Tissue Proteins; Orthomyxoviridae Infections; Protein Multimerization; Proteostasis; Synucleinopathies | 2020 |